DCF — EISENHOWER MEDICAL CENTER
Enterprise Value: $-1.9B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-1.9B
Enterprise Value
$-596.0M
PV of Cash Flows
$-1.3B
PV of Terminal Value
$-2.1B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $1.1B | $-120.3M | -11.0% | $-165.5M | $-150.5M |
| Year 2 | $1.1B | $-112.9M | -10.0% | $-159.5M | $-131.8M |
| Year 3 | $1.1B | $-105.0M | -9.0% | $-152.9M | $-114.9M |
| Year 4 | $1.2B | $-102.3M | -9.0% | $-151.7M | $-103.6M |
| Year 5 | $1.2B | $-102.4M | -9.0% | $-153.2M | $-95.2M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-1.9B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$1.0B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.11769085237986873
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5